Asian Stocks Set to Track US Gains as Virus Treatment Hopes Lift Confidence

A top US health official said Gilead Sciences Inc's antiviral drug remdesivir is likely to become the standard of care for Covid-19 after early results from a clinical trial showed it helped certain patients recover more quickly.

from Top Business News- News18.com https://ift.tt/2VPt5SR
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Beyond Borders: The True Origins Of India's Favorite Brands - Colgate, Bata And Maruti

Bata grew into one of the world's leading shoemakers, with an impressive annual sale of 150 million pairs of shoes across more than 70 c...